BURLINGTON, Mass., Nov. 29, 2016 -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will participate in the Benchmark Company Micro Cap Discovery One-on-One Investor Conference on Thursday, December 1, 2016 at the Palmer House Hilton in Chicago, IL.
For more information or to register, please visit the conference website at www.benchmarkcompany.com/conference.php.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at www.lemaitre.com.
Contact: LeMaitre Vascular, Inc. Steven Chehames Investor Relations +1-781-425-1659 [email protected]


UPS and Teamsters Reach Agreement to Limit Driver Severance Program
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Deere & Company Agrees to $99 Million Settlement Over Right-to-Repair Dispute
Apple's Foldable iPhone Faces Engineering Setbacks, Mass Production Timeline at Risk
Britain Courts Anthropic Amid US Defense Department Dispute
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO 



